Identification of circulating proteins associated with general cognitive function among middle-aged and older adults
DEBETTE, Stephanie
Institut des Maladies Neurodégénératives [Bordeaux] [IMN]
Bordeaux population health [BPH]
< Réduire
Institut des Maladies Neurodégénératives [Bordeaux] [IMN]
Bordeaux population health [BPH]
Langue
EN
Article de revue
Ce document a été publié dans
Communications Biology. 2023-11-03, vol. 6, n° 1, p. 1117
Résumé en anglais
Identifying circulating proteins associated with cognitive function may point to biomarkers and molecular process of cognitive impairment. Few studies have investigated the association between circulating proteins and ...Lire la suite >
Identifying circulating proteins associated with cognitive function may point to biomarkers and molecular process of cognitive impairment. Few studies have investigated the association between circulating proteins and cognitive function. We identify 246 protein measures quantified by the SomaScan assay as associated with cognitive function (p<4.9E-5, n up to 7289). Of these, 45 were replicated using SomaScan data, and three were replicated using Olink data at Bonferroni-corrected significance. Enrichment analysis linked the proteins associated with general cognitive function to cell signaling pathways and synapse architecture. Mendelian randomization analysis implicated higher levels of NECTIN2, a protein mediating viral entry into neuronal cells, with higher Alzheimer's disease (AD) risk (p=2.5E-26). Levels of 14 other protein measures were implicated as consequences of AD susceptibility (p<2.0E-4). Proteins implicated as causes or consequences of AD susceptibility may provide new insight into the potential relationship between immunity and AD susceptibility as well as potential therapeutic targets. Analysis of circulating proteins across multiple cohorts identifies proteins that are associated with cognitive function and may serve as targets to understand the relationship between immunity and Alzheimer's disease risk.< Réduire
Project ANR
Stopping cognitive decline and dementia by fighting covert cerebral small vessel disease